Xenetic Biosciences (XBIO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Voting matters and shareholder proposals
Election of six directors: Grigory Borisenko, Firdaus Jal Dastoor, Dmitry Genkin, Roger Kornberg, Moshe Mizrahy, and Alexey Vinogradov is proposed for the upcoming annual meeting.
Ratification of CBIZ CPAS P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, is up for shareholder approval.
A non-binding advisory vote on named executive officer compensation is included on the agenda.
The proxy may vote on other business that may properly come before the meeting or any adjournment.
Board of directors and corporate governance
Six nominees are presented for election to the board at the annual meeting.
Executive compensation and say-on-pay
Shareholders are asked to provide a non-binding advisory vote on executive compensation for named executive officers.
Latest events from Xenetic Biosciences
- Progressed DNase-based oncology pipeline, increased royalties, and raised cash via public offering.XBIO
Q4 202513 Mar 2026 - DNase I shows promise in overcoming immunotherapy resistance in colorectal cancer models.XBIO
Status Update12 Jan 2026 - No quorum was reached, so the meeting was adjourned and will be rescheduled.XBIO
AGM 20258 Jan 2026 - Up to $50M in securities may be offered to fund clinical and corporate initiatives amid high development risk.XBIO
Registration Filing16 Dec 2025 - Annual meeting adjourned for lack of quorum; reconvened for January 8, 2026, with voting ongoing.XBIO
Proxy Filing11 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and key governance matters.XBIO
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay proposals.XBIO
Proxy Filing2 Dec 2025 - Q3 2025 revenue up 67% to $1.03M; $3.9M equity raise extends runway amid strategic review.XBIO
Q3 202513 Nov 2025 - Annual meeting to vote on directors, auditor ratification, and executive pay, with new auditor named.XBIO
Proxy Filing31 Oct 2025